This article was first published by The Times of Israel and was re-posted with permission.
American pharmaceutical company CannRx and accelerator iCAN: Israel-Cannabis have partnered to launch a sleep aid, called ican.sleep, made from cannabis extracts. The product will be the first pharmaceutical-grade cannabis formulation for sleep on the market, and could be a boon for the pharmaceutical industry in Israel, said Bill Levine, the executive chairman of CannRx Technologies.
The product will consist of a precise cannabis formulation that will be inhaled by users for a rapid onset. The formulation will also determine the duration of users’ sleep.
“You take a puff or two, depending upon the dosage, and basically within ten minutes you’ll be drowsy enough to sleep,” Levine said. “We can give you a predictable, dose dependent response every single time.”
The companies announced the new product at the CannaTech medical
... read more at: http://nocamels.com/2017/03/israeli-cannabis-sleep-aid/